Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03557125 · ClinicalTrials.gov registry record · NA

Quadratus Lumborum Block for Analgesia Following Hip Arthroscopy

A NA study of Surgery, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
46
Enrollment target
1
Study location

NCT03557125: Completed NA study of Surgery, sponsored by Medical University of South Carolina.

NCT03557125 is a NA study of Surgery that has completed, run by Medical University of South Carolina. The registered enrollment target is 46 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03557125, a NA study of Surgery, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

Evaluate difference in postoperative opiate consumption when patients do or do not receive a quadratus lumborum block preoperatively for hip arthroscopy.

Primary Outcome

opioid consumption including intraoperative consumption exceeding 100µg of fentanyl and all postoperative opioid consumption in the postoperative anesthesia care unit (PACU).

Conditions Studied

Interventions

  • OTHER QL Block
  • OTHER Saline Skin Wheel

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2018-05-22
Est. Completion 2020-03-14
Phase NA

What the finished NCT03557125 record still lists

NCT03557125 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which QL Block is the first listed.

NCT03557125 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT03557125 about?

NCT03557125 is a clinical study titled "Quadratus Lumborum Block for Analgesia Following Hip Arthroscopy". Evaluate difference in postoperative opiate consumption when patients do or do not receive a quadratus lumborum block preoperatively for hip arthroscopy.

What is the current status of trial NCT03557125?

This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2018-05-22. Estimated completion is 2020-03-14.

What conditions does trial NCT03557125 study?

This clinical trial studies the following conditions: Surgery.

What interventions are being tested in trial NCT03557125?

The interventions under investigation include: QL Block (OTHER), Saline Skin Wheel (OTHER).

Who is sponsoring clinical trial NCT03557125?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03557125 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03557125's enrollment target sits among peer trials

46 95th of 120 higher than 26 of 120 other Surgery trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03557125, the US trial registry maintained by the National Library of Medicine. NCT03557125 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.